Ningbo Menovo Pharmaceutical Co., Ltd. (SHA:603538)
26.07
+2.37 (10.00%)
Aug 8, 2025, 2:45 PM CST
Theseus Pharmaceuticals Market Cap
SHA:603538 has a market cap or net worth of 5.21 billion as of August 8, 2025. Its market cap has increased by 96.18% in one year.
Market Cap
5.21B
Enterprise Value
6.01B
Revenue
1.39B
Ranking
n/a
PE Ratio
69.96
Stock Price
$26.07
Market Cap Chart
Since April 7, 2017, SHA:603538's market cap has increased from 2.42B to 5.21B, an increase of 114.93%. That is a compound annual growth rate of 9.61%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 7, 2025 | 5.21B | 87.38% |
Dec 31, 2024 | 2.78B | -31.86% |
Dec 29, 2023 | 4.08B | -25.74% |
Dec 30, 2022 | 5.49B | 3.44% |
Dec 31, 2021 | 5.31B | -4.38% |
Dec 31, 2020 | 5.55B | 50.31% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Apr 7, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Jiangsu Hengrui Medicine | 411.71B |
Shenzhen Mindray Bio-Medical Electronics | 275.78B |
WuXi AppTec | 267.08B |
Sichuan Biokin Pharmaceutical | 122.78B |
Zhangzhou Pientzehuang Pharmaceutical., | 121.57B |
Aier Eye Hospital Group | 119.17B |
Shanghai United Imaging Healthcare | 105.91B |
Yunnan Baiyao Group Co.,Ltd | 99.85B |